DocuSign, Inc. (NASDAQ:DOCU) Receives $92.45 Consensus PT from Analysts

Shares of DocuSign, Inc. (NASDAQ:DOCUGet Free Report) have been assigned an average recommendation of “Hold” from the thirteen brokerages that are presently covering the stock, Marketbeat Ratings reports. Three analysts have rated the stock with a sell rating, seven have given a hold rating and three have given a buy rating to the company. The average twelve-month price target among analysts that have issued ratings on the stock in the last year is $92.45.

Several research analysts have issued reports on DOCU shares. Piper Sandler increased their price target on DocuSign from $60.00 to $90.00 and gave the stock a “neutral” rating in a report on Friday, December 6th. Wells Fargo & Company increased their target price on DocuSign from $50.00 to $70.00 and gave the stock an “underweight” rating in a report on Friday, December 6th. Robert W. Baird boosted their price target on shares of DocuSign from $59.00 to $100.00 and gave the company a “neutral” rating in a research note on Friday, December 6th. JPMorgan Chase & Co. raised their price objective on shares of DocuSign from $50.00 to $70.00 and gave the company an “underweight” rating in a research note on Tuesday, December 3rd. Finally, HSBC reissued a “reduce” rating on shares of DocuSign in a research report on Friday, December 6th.

View Our Latest Report on DocuSign

DocuSign Trading Down 1.8 %

Shares of NASDAQ DOCU opened at $81.70 on Friday. The firm’s 50-day moving average price is $90.14 and its 200-day moving average price is $78.07. The firm has a market capitalization of $16.51 billion, a P/E ratio of 16.85, a P/E/G ratio of 6.94 and a beta of 0.89. DocuSign has a 1-year low of $48.70 and a 1-year high of $107.86.

Insider Transactions at DocuSign

In related news, CFO Blake Jeffrey Grayson sold 8,000 shares of the business’s stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $86.90, for a total value of $695,200.00. Following the transaction, the chief financial officer now directly owns 77,851 shares of the company’s stock, valued at approximately $6,765,251.90. The trade was a 9.32 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Daniel D. Springer sold 581,588 shares of the stock in a transaction dated Tuesday, December 10th. The shares were sold at an average price of $97.04, for a total transaction of $56,437,299.52. Following the transaction, the director now owns 906,430 shares of the company’s stock, valued at approximately $87,959,967.20. The trade was a 39.08 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 686,010 shares of company stock worth $66,102,694 in the last 90 days. Insiders own 1.66% of the company’s stock.

Institutional Investors Weigh In On DocuSign

A number of hedge funds have recently modified their holdings of the stock. Fluent Financial LLC bought a new position in DocuSign during the fourth quarter valued at $694,000. Total Wealth Planning & Management Inc. bought a new position in shares of DocuSign during the 4th quarter worth $312,000. Universal Beteiligungs und Servicegesellschaft mbH bought a new position in shares of DocuSign during the 4th quarter worth $14,463,000. Putney Financial Group LLC purchased a new stake in DocuSign in the 4th quarter worth about $65,000. Finally, Forum Financial Management LP bought a new stake in DocuSign in the 4th quarter valued at about $773,000. Institutional investors own 77.64% of the company’s stock.

About DocuSign

(Get Free Report

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

Featured Stories

Analyst Recommendations for DocuSign (NASDAQ:DOCU)

Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.